Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A man developed skin issues from cancer medication, which improved with specific treatments.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

These new skin treatments are safer and more effective with minimal side effects.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Upadacitinib may cause hair loss.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Upadacitinib effectively treats pyoderma gangrenosum.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.